Showing 4 results

How effective are new drugs in delaying disability progression in relapsing remitting onset multiple sclerosis? A subgroup analysis

• MS-2-802, Box 25, Folder 11
• Item
• 2006

Part of Murray G. Brown fonds

Information sinkholes on the road to representative estimates of MS disability progression speed ....

• MS-2-802, Box 24, Folder 4
• Item
• 2014

Part of Murray G. Brown fonds

Modelling health outcomes in relapsing-remitting-onset multiple sclerosis cohorts treated with disease-modifying drugs that delay disability progression

• MS-2-802, Box 23, Folder 5
• Item
• 2010

Part of Murray G. Brown fonds

Multiple sclerosis disease-modifying drug and health care costs in Nova Scotia, 1989 -2003 / Vern Hicks, Murray G. Brown, I.S. Sketris

• MS-2-802, Box 25, Folder 8
• Item
• 2006

Part of Murray G. Brown fonds